4.6 Review

Drug development in Alzheimer's disease: the path to 2025

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

James A. Hendrix et al.

ALZHEIMERS & DEMENTIA (2016)

Article Clinical Neurology

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric R. Siemers et al.

ALZHEIMERS & DEMENTIA (2016)

Article Clinical Neurology

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

Jinping Wang et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

LANCET (2016)

Article Clinical Neurology

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease

Jeffrey L. Cummings et al.

ALZHEIMERS RESEARCH & THERAPY (2016)

Editorial Material Pharmacology & Pharmacy

Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success

Haruhiko Sugino et al.

CLINICAL THERAPEUTICS (2015)

Editorial Material Pharmacology & Pharmacy

The Future Is Now: Model-Based Clinical Trial Design for Alzheimer's Disease

K. Romero et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)

Article Clinical Neurology

THE ALZHEIMER'S PREVENTION INITIATIVE

Pierre N. Tariot et al.

Alzheimers & Dementia (2014)

Article Medicine, General & Internal

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

David B. Henley et al.

CURRENT MEDICAL RESEARCH AND OPINION (2014)

Article Medicine, General & Internal

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

L. S. Schneider et al.

JOURNAL OF INTERNAL MEDICINE (2014)

Review Clinical Neurology

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois et al.

LANCET NEUROLOGY (2014)

Article Multidisciplinary Sciences

A three-dimensional human neural cell culture model of Alzheimer's disease

Se Hoon Choi et al.

NATURE (2014)

Article Clinical Neurology

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

Jeffrey L. Cummings et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Clinical Neurology

The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline

Michael C. Donohue et al.

JAMA NEUROLOGY (2014)

Article Pharmacology & Pharmacy

Repackaging FDA-approved drugs for degenerative diseases: promises and challenges

Jeffrey L. Cummings et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)

Review Chemistry, Medicinal

Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications

Brian S. Appleby et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)

Review Geriatrics & Gerontology

A Review: Treatment of Alzheimer's Disease Discovered in Repurposed Agents

Brian S. Appleby et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)

Article Multidisciplinary Sciences

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer's Disease

Laura B. Zahodne et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model

Pascal E. Sanchez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Clinical Neurology

Current Alzheimer's disease clinical trials: Methods and placebo outcomes

Lon S. Schneider et al.

ALZHEIMERS & DEMENTIA (2009)